Jan Cools, Editor in Chief of HemaSphere, journal of EHA at European Hematology Association (EHA), shared a post on LinkedIn:
“Proud to see this super interesting study published in HemaSphere Journal, the journal of European Hematology Association (EHA):
This work by Pablo Menendez Bujan and co-workers generated a single-cell expression atlas of 119,000 AML cells and AML stem cells in paired diagnostic-relapse samples and identify the role of the HIF pathway in drug resistance. They demonstrate that chemical inhibition of HIF cooperates with standard-of-care chemotherapy to impair AML growth and eliminate AML stem cells“.
View the article.
Source: Jan Cools/LinkedIn